⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 33 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
🧸 Product IT BG DK EE ES FI FR GR HR IE LU THE NETHERLANDS PL SE SI February 7, 2020

Piaggio — Vespa GTS 125-300, Vespa GTV300

Motorcycle.

Risk level
Serious risk
Type
Injuries
Category
Motor vehicles
Hazard
The brake line terminals might have been incorrectly galvanised.
Origin
Italy

⚖️ Actions ordered by authorities

  • ▸ Measures ordered by economic operators (to: Manufacturer) Recall of the product from end users
🗄
Archived (older alert)
This alert was reported 2409 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
118 days in total
May 17, 2026 September 12, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? This is about some Vespa scooters made by Piaggio. A small part on the brakes may not be safe.

What's happening? The brake line terminals might be weak. This could cause brake problems.

Does this affect me? If you own one of these Vespas, you could be at risk.

What should I do? Stop riding it and ask a mechanic or your Piaggio dealer for help.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
Piaggio
Agency-published detail

Risk level: Serious risk · Type: Injuries · Category: Motor vehicles · Hazard: The brake line terminals might have been incorrectly galvanised. · Origin: Italy

First published
February 7, 2020
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10000218

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this product recall alert about?
Piaggio — Vespa GTS 125-300, Vespa GTV300. Risk level: Serious risk · Type: Injuries · Category: Motor vehicles · Hazard: The brake line terminals might have been incorrectly galvanised. · Origin: Italy
▸ When was this alert issued?
This alert was issued on February 7, 2020 by EU Safety Gate.
▸ Which countries are affected?
The alert applies to the following countries: Italy, Bulgaria, Denmark, Estonia, Spain, Finland, France, Greece, Croatia, Ireland, Luxembourg, THE NETHERLANDS, Poland, Sweden, and Slovenia.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
▸ Where can I find the official notice?
The full official notice is published on ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.